P lasminogen activator inhibitor 1 (PAI-1) is a multifunctional protein that is best known for its regulation of plasminogen activation. 1 It rapidly forms inactive complexes with the serine proteases tissue-type and urokinase-type (uPA) plasminogen activator, thereby preventing the conversion of plasminogen into plasmin. Furthermore, PAI-1 binds to vitronectin (VN), an adhesive, extracellular matrix protein. It has been shown that the binding of PAI-1 to VN affects the migration of smooth muscle cells (SMCs) by preventing the binding of VN to the ␣ v ␤ 3 integrin. 2 
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Delineating the role of PAI-1 in atherogenesis and restenosis is particularly cumbersome, partially as a result of the different design of experimental models that often accentuate a single feature of the human pathology. For instance, comparison of mechanical and electrical injury-induced intima formation in PAI-1-deficient ( Ϫ/Ϫ ) and wild-type mice revealed that PAI-1 blocks intimal thickening by inhibiting the migration of SMCs. 3 Moreover, PAI-1-overexpressing SMCs, seeded on a denuded carotid artery, inhibited intima formation as the result of decreased SMC migration. 4 In contrast, by using a copper-or ferrichloride-induced oxidative vascular injury model, PAI-1 deficiency attenuated lesion formation. [5] [6] [7] Contradictory observations have been noted in high-fat, macrophage-rich/ SMC-poor models (apoE Ϫ/Ϫ and/or LDLR Ϫ/Ϫ mice), revealing that PAI-1 deficiency may reduce, enhance, or not influence lesion formation, possibly depending on strain differences. 8 -10 In addition, in a balloon-injured rat carotid artery model, PAI-1 overexpression resulted in increased SMC proliferation that was associated with fibrin accumulation. 11 In the murine carotid artery ligation model, formation of a fibrin matrix apparently accounted for increased intima formation in uPA Ϫ/Ϫ mice, whereas PAI-1 Ϫ/Ϫ mice responded like wild-type mice. 12 However, in similar study that used the carotid artery ligation model, decreased intima formation was observed in VN Ϫ/Ϫ and PAI-1 Ϫ/Ϫ mice. 7 A satisfactory explanation for these discrepancies is presently not available, but it is possible that the different models and/or methodologies accentuate the various, distinct functions of PAI-1.
Here, we studied the role of PAI-1 as a local thrombin inhibitor in SMC proliferation by using the carotid artery ligation model, which mimics restenosis after angioplasty. In this model, the endothelium remains intact, and lesions virtually lack infiltrating cells. 13 It is assumed that reduced shear stress, hypoxia, and arterial wall pressure are determinants for intima formation as a result of SMC proliferation. 14 A possible function for PAI-1 in controlling SMC proliferation is suggested by the following observations and explored in this study. First, PAI-1 inhibits thrombin in vitro, provided either VN or heparin is present as a cofactor. [15] [16] [17] Second, thrombin is a potent mitogen for cultured SMCs. 18, 19 Accordingly, the thrombin-specific inhibitor hirudin significantly reduces intima formation in various animal models. 20 -22 Third, the presence of active thrombin, as well as active PAI-1, was reported in human atherosclerotic lesions. 23, 24 Moreover, the latter studies revealed colocalization of thrombin, PAI-1, and VN, supporting the potential significance of PAI-1/VN complexes in regulating the mitogenic activity of thrombin. 23 Importantly, the (atherosclerotic) vessel wall is virtually devoid of the traditional plasma thrombin inhibitors, 25 whereas PAI-1 is synthesized by vascular cells and abundantly present in lesions. 26, 27 Similarly, large amounts of prothrombin and VN have been encountered in the human vessel wall. 25, 28 In addition, components of the intrinsic and extrinsic coagulation pathway are encountered in diseased vessels, suggesting that prothrombin can be activated. 25 Hence, the requirements are met for controlling thrombin activity by PAI-1/VN complexes in the vessel wall.
Here, we used the carotid artery ligation model in PAI-1
, and wild-type mice to explore the effect of PAI-1 and VN on intima formation. 13 We report that increased intima formation is observed in PAI-1 Ϫ/Ϫ and VN Ϫ/Ϫ mice as compared with wild-type mice. Excessive intima formation in PAI-1 Ϫ/Ϫ mice is inhibited by the thrombin-specific inhibitor hirudin. These results provide support for a function of PAI-1/VN complexes in thrombin-mediated SMC proliferation.
Methods

Mice and Experimental Protocol
Breeding of PAI-1 Ϫ/Ϫ mice and backcrossing with wild-type C57Bl6/6J has been described. 29 VN Ϫ/Ϫ mice were kindly provided by Randal Westrick and Dr. David Ginsburg (University of Michigan, Ann Arbor,). 30 VN Ϫ/Ϫ mice had been backcrossed for at least 8 generations with C57Bl/6J (Charles River Laboratories Inc., IffaCredo, l'Arbresle, France). All mice were maintained on a standard chow diet. The mice used were 2 to 4 months old and weighed 20 to 30 g. Ligation of the left carotid artery, near the distal bifurcation, was performed as described previously. 13 The mice were sacrificed either at 2.5 or 4 weeks after ligation of the carotid artery. Four to five mice were used for each time point. In a subsequent carotid artery ligation experiment, only wild-type and PAI-1 Ϫ/Ϫ mice were used, which were then subjected to daily subcutaneous injections with placebo (50 mg/mL D-mannitol; Merck) or polyethylene glycol (PEG)-hirudin (1 mg/kg body weight; kindly provided by Dr. Klaus Rübsamen and Dr. Wilfried Hornberger, Knoll AG, Ludwigshafen, Germany) in 50 mg/mL D-mannitol. Seven to eight mice were used in this experiment. All mice were operated and sacrificed under ketamine/xylazine anesthesia and subsequently fixed by perfusion with 4% (v/v) paraformaldehyde in PBS. The carotid arteries were excised, immersion fixed in 70% (v/v) ethanol, and embedded in paraffin. The nonligated, right carotid artery served as internal control and was embedded together with the ligated vessel. Serial sections of 5 m were cut for morphometric analysis. After sectioning and mounting on Superfrost Plus slides (Menzel-Gläser), the specimens were subjected to hematoxylin-eosin staining. Animal care and experimental procedures were approved by the local Ethical Committee on Animal Experiments.
Morphometry
The ligated carotid artery was sectioned from the ligature toward the aortic arch. A standardized reference point was set at which location the ligature did not distort the vessel and where elastic laminae were intact. The reference point is situated between 0.05 mm and 0.13 mm from the ligation. Cross sections at 0.2, 0.3, and 0.4 mm from the reference point were morphometrically analyzed by using the QWin software (Leica Microsystems) on digital images of the vessel, obtained with a Sony DXC-950 3CCD color videocamera. The circumferences of the lumen, internal elastic lamina (IEL), and external elastic lamina (EEL) were measured by tracing along the luminal surface, IEL, and EEL. The medial area (M) was calculated by subtracting the area within the IEL from the area defined by the EEL. Similarly, the intimal area (I) was calculated by subtracting the luminal area from the IEL area. The circumference of the control nonligated carotid artery is independent of the ligation time and identical between deficient and wild-type mice. To establish vascular remodeling, the total vessel area of the ligated carotid arteries (EEL of the left carotid) is expressed as percentage of the total vessel area of the nonligated artery (EEL of the right carotid).
Immunohistochemistry
Paraffin sections (5 m) were deparaffinized, rehydrated, and incubated with 0.3% hydrogen peroxide and blocked with 10% (v/v) preimmune goat serum (DAKO). Subsequently, sections were incubated overnight at 4°C with primary antibodies, followed by incubation with biotinylated secondary rat antimurine light-chain antiserum or goat antirabbit antiserum, which were detected with streptavidin-horseradish peroxidase conjugates (DAKO) and, subsequently, with amino-ethylcarbazole and hydrogen peroxide. After counterstaining with hematoxylin, sections were embedded in glycergel (Sigma). Proliferating cell-nuclear antigen (PCNA) staining was performed by using an anti-PCNA monoclonal antibody (DAKO) with 0.1% (v/v) Triton X-100. Antigen retrieval was performed by boiling three times for 5 minutes at 700 Watt in a microwave in citrate buffer (pH 6). A polyclonal anti-PAI-1 antiserum was kindly provided by Dr. D.J. Loskutoff (The Scripps Research Institute, La Jolla, Calif) and used as in the PCNA-staining protocol. A polyclonal antimurine VN antiserum was obtained from Molecular Innovations Inc. A polyclonal antiserum against murine thrombin was kindly provided by Dr. J. Timmerman (this institute) and affinity-purified on a thrombin-containing column.
Thrombin Activity and Hirudin Assays
Thrombin-mediated coagulation was determined with the Pathromtin SL kit to measure the activated partial thromboplastin time (APTT) of citrated plasma samples from wild-type and PAI-1 Ϫ/Ϫ mice by using the BCS Coagulation System (Dade Behring). Plasma was incubated with phospholipids and calcium to trigger coagulation, and time to clot formation was recorded. The activity of PEG-hirudin was measured by using a hirudin-activity assay in the BCS Coagulation System. Hirudin inactivates a fixed amount of added thrombin: Residual thrombin activity is determined by continuously measuring the increase in absorbance (405 nm) caused by conversion of the chromogenic substrate tosylglycyl-L-prolyl-L-arginyl-5-amino-2-nitrobenzoic acid isopropylamide. On the final experimental day, the mice received a last placebo or PEG-hirudin injection. Blood collection and subsequent sacrifice of the mice started at least 1 hour after the above-mentioned injections.
Statistical Analysis
All statistical analyses were performed with the SPSS version 10.0.5 software. Experimental values are expressed as meanϮstandard deviation. The significance of differences in intima formation between the PAI-1 Ϫ/Ϫ , VN Ϫ/Ϫ , and the corresponding wild-type groups was determined by using a nonparametric test (Mann-Whitney U 2-tailed test with a significance of PϽ0.05).
Results
Vascular Remodeling in Ligated Carotid Arteries of VN
؊/؊ , PAI-1 ؊/؊ , and Wild-Type Mice
The total vessel area was measured in ligated carotids at set distances from the reference point ( Figure 1A) . By comparing the vessel area of nonligated with the ligated carotid arteries of wild-type mice ( Figure 1B and 1C Figure  1D ) and PAI-1 Ϫ/Ϫ mice ( Figure 1F ) as compared with the wild-type mice ( Figure 1C and 1E ), which is significant as shown ( Figure 1G and 1H ). This observation is presumably the result of the increased number of cells present in the intima of the deficient mice that counteracts the remodeling process at these latter time points. It reveals that luminal narrowing in ligated carotids is not exclusively because of constrictive remodeling. A significant part of the lumen is narrowed by a stenosis, largely composed of SMCs ( Figure   1C through 1F) . Consequently, the VN Ϫ/Ϫ and PAI-1 Ϫ/Ϫ mice display a substantially larger intima than wild-type mice.
Intima of Ligated Carotid Arteries of VN
We measured the length of the lesion by counting the number of sections containing intimal SMCs, and determined the intima/ media (I/M) ratio for the deficient and wild-type mice. Clearly, the lesions of both VN Ϫ/Ϫ (Figure 2A ) and PAI-1 Ϫ/Ϫ mice ( Figure 2B ) were substantially longer than those of wild-type mice. At 2.5 and 4 weeks after ligation, the intimal lesion in VN Ϫ/Ϫ mice was approximately 1.5-fold longer than that of the corresponding wild-type mice. PAI-1 Ϫ/Ϫ mice displayed a 2-fold longer lesion than their wild-type counterparts.
The I/M ratios were calculated on morphometric analysis of sections of ligated carotid arteries that were taken at a fixed distance (0.3 mm) from the reference point. For VN Ϫ/Ϫ mice, the I/M ratio after 2.5 weeks of ligation was 5-fold higher than for wild-type mice ( Figure 2C ). After 4 weeks of ligation, a 2.5-fold increase was observed. The wild-type mice had a similar I/M ratio after 2.5 and 4 weeks of ligation. After 2.5 weeks of ligation, the I/M ratio of PAI-1 Ϫ/Ϫ mice was 5-fold higher than that of the corresponding wild-type mice ( Figure 2D ). After 4 weeks of ligation, a further enlargement of the intimal area caused a 7-fold increase of I/M ratio. Taken together, we conclude that after carotid artery ligation, a longer lesion and a higher I/M ratio is generated in PAI-1 Ϫ/Ϫ and VN Ϫ/Ϫ mice as compared with the corresponding wild-type mice.
SMC Proliferation
To determine whether larger intimal lesions are caused by SMC proliferation, we counted the nuclei present in sections that were also used for morphometric measurements. For VN Ϫ/Ϫ mice, the cell number after 2.5 weeks of ligation was 4-fold higher than for the wild-type mice ( Figure 3A) . After 4 weeks of ligation, a 2.5-fold increase was seen. Wild-type mice had a comparable number of cells present in the intima after 2.5 and 4 weeks of ligation. In PAI-1 Ϫ/Ϫ mice, an increased cell number was seen after both 2.5 and 4 weeks of ligation ( Figure 3B ). After 2.5 weeks, the cell number was 9-fold higher than that of the corresponding wild-type mice. Although the lesion had increased after 4 weeks of ligation in the PAI-1 Ϫ/Ϫ mice, the increase in cell number was only 6-fold compared with the wild-type mice. This is explained by the 2-fold increase in cell number of the wild-type mice. To further substantiate the increase in cell number observed and to establish whether these cells are actively engaged in proliferation, PCNA staining was performed. After 2.5 weeks of ligation, both VN Ϫ/Ϫ ( Figure 3C ) and PAI-1 Ϫ/Ϫ mice ( Figure 3D ) had an increased number of PCNA-stained cells, whereas wild-type mice only showed an occasional PCNA-stained cell in their minute lesions. After 4 weeks of ligation, the PAI-1 Ϫ/Ϫ mice still had an increased number of PCNA-stained cells. However, at this time point, the number of PCNA-staining cells was diminished in the VN Ϫ/Ϫ mice, being the same as for the wild-type counterparts. In conclusion, the data on cell numbers measured by two different methods agree with those recorded for I/M ratios.
Hirudin Affects Intima Formation
We measured thrombin-mediated coagulation activity in plasma as a surrogate value for prothrombin levels in the vessel wall. 25 The clotting values for VN
, and wild-type genotypes are not significantly different (see online Figure I , which can be accessed at http://atvb.ahajournals.org). Therefore, prothrombin availability is considered similar in all genotypes studied.
To provide evidence for a role of thrombin in intima formation in PAI-1 Ϫ/Ϫ and wild-type mice, we assessed the effect of the thrombin-specific inhibitor hirudin. To that end, we injected PEG-hirudin and measured its bioactivity in plasma of placeboand PEG-hirudin-treated mice. In PEG-hirudin-treated mice, 3% to 5% (0.3 to 0.5 g/mL plasma) of the injected PEGhirudin (10 g/mL plasma) was recovered ( Figure 4A ). No significant difference was observed between wild-type and PAI-1 Ϫ/Ϫ mice. Yet, the amount of PEG-hirudin encountered is responsible for a 2-fold longer APTT ( Figure 4B ).
Carotid artery ligations were performed and I/M ratios were calculated. The I/M ratio of placebo-treated PAI-1 Ϫ/Ϫ mice was 2-fold higher than that of placebo-treated wild-type mice ( Figure  4C ). In wild-type mice, PEG-hirudin did not cause an alteration of the I/M ratio as compared with placebo-treated wild-type mice. However, in PAI-1 Ϫ/Ϫ mice, PEG-hirudin significantly reduced the I/M ratio, reaching the level of placebo-or hirudintreated wild-type mice.
Presence of VN, PAI-1, and Prothrombin
To verify the presence of the components studied, immunohistochemical detection of VN, PAI-1, and prothrombin was performed in ligated carotids. VN antigen was predominantly present in the adventitia and in the intima of wild-type and PAI-1 Ϫ/Ϫ mice ( Figure 5A ). PAI-1 antigen was found almost exclusively in the intima of wild-type and VN Ϫ/Ϫ mice after 2.5 and 4 weeks of ligation ( Figure 5B) . Furthermore, PAI-1 was encountered both cell associated and in the extracellular matrix. Prothrombin, a plasma-derived protein, was unevenly distributed in the intima and media ( Figure 5C ). Consequently, all three proteins were present in the intima of ligated arteries, thus potentially positioned to interact.
Discussion
We used the murine carotid artery ligation model to study the role of PAI-1 and VN in (re)stenosis. 13 In this model, the size of the intima relies greatly on SMC proliferation because the 
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contribution of other vascular cell types is negligible. The main conclusion on the data obtained in this study is that PAI-1 and VN prevent intima formation, exemplified by substantially longer lesions and I/M ratios in PAI-1 Ϫ/Ϫ and VN Ϫ/Ϫ mice than in the corresponding wild-type mice. Although PAI-1 has been implicated in various processes relevant to atherogenesis and (re)stenosis, ranging from (indirect) control of plasmin-mediated transforming growth factor-␤ activation and subsequent induction of platelet-derived growth factor, 31 metalloproteinase activation, 32 inhibition of uPA-mediated cell migration, 33 to cellular adhesion, and detachment by virtue of its overlapping VNbinding site with ␣ v integrins and the urokinase receptor, 34 our data point to a role for PAI-1, in conjunction with VN, in SMC proliferation. Significantly, excessive intima formation in PAI-1 Ϫ/Ϫ mice is largely dependent on mitogenic activity of thrombin, because hirudin reduces intima formation to that of corresponding wild-type mice.
Seemingly contradictory data on the role of PAI-1 have been reported by using adenovirus-mediated overexpression of PAI-1 in a rat vascular injury model. 10 Excess of PAI-1 resulted in SMC proliferation that correlated with persistent fibrin(ogen) accumulation, presumably caused by the PAI-1-mediated inhibition of fibrinolysis. 11 In contrast to the rat vascular injury model, carotid artery ligation is not based on injury because the endothelial-cell layer remains intact. 13 Consequently, after 1 week of ligation, a thrombus is rarely observed in any of our studied genotypes, confirming previous observations. 14, 35 At this time point, virtually no intima has been generated. Thus, in our hands, there are no indications that thrombus formation plays a prominent role in the carotid artery ligation model. By contrast, Peng and collaborators 7 recently used the carotid artery ligation model and observed decreased intima formation in PAI-1 Ϫ/Ϫ mice as compared with wild-type mice. These authors assumed that thrombi had been generated and attributed a cell migration-promoting role to fibrin, which would be diminished in the absence of PAI-1, because of increased fibrinolysis. Apart from fibrin formation, an essential methodological discrepancy is that their measurements of intima size were performed at a considerably larger distance from the ligature (2 to 7 mm) than in our experiments (0.05 to 1.5 mm), apparently spanning an area that does not harbor proliferating SMC.
Hirudin-mediated reduction in intima formation is observed in PAI-1 Ϫ/Ϫ mice; however, no effect of hirudin was seen on the small lesions of wild-type mice. It is conceivable that, simultaneous with thrombin, other determinants function to ultimately induce SMC proliferation (eg, stasis, hypoxia, arterial wall pressure). Such factors are insensitive to hirudin. Yet, the discrepancy might also be explained by previous observations with cultured SMCs, showing that thrombin induces PAI-1 synthesis in these cells. 36 In addition, we and others [15] [16] [17] demonstrated previously that thrombin is a target serine proteinase for PAI-1/VN complexes in vitro. Hence, in this environment, thrombin provides for control of its own activity. Obviously, this feedback loop is not existent in PAI-1 Ϫ/Ϫ mice, resulting in abundant thrombin activity and, consequently, excessive SMC proliferation. Collectively, apart from other functions of PAI-1 and VN, the interaction between thrombin and PAI-1/VN complexes is conceivably relevant for the generation of SMCrich intima.
The interaction between thrombin and PAI-1/VN complexes is characterized by a so-called suicide-substrate mechanism. 17 This mechanism consists of two separate pathways for the fate of PAI-1, namely the generation of covalent thrombin/PAI-1 complexes (ie, suicide reaction) and the cleavage of PAI-1 and recovery of active thrombin (ie, substrate reaction). In the latter case, thrombin removes active PAI-1 from the vascular compartment and thereby eliminates not only its own inhibitor but also that of other target proteases, notably uPA. Because uPA is primarily responsible for the migration of SMCs, 33 the ultimate effect of the substrate reaction is to remove the uPA inhibitor and, consequently, an indirect promotion of migration by thrombin. Alternatively, if the suicide reaction prevails, then PAI-1 predominantly forms covalent complexes with thrombin, resulting in inhibition of thrombin-mediated SMC proliferation. We believe that the data reported here favor the latter explanation because we observed an increased cell number and PCNAexpressing cells in the intima of PAI-1 Ϫ/Ϫ and VN Ϫ/Ϫ mice. Finally, it should be noted that the kinetics of intima formation in PAI-1 Ϫ/Ϫ and VN Ϫ/Ϫ mice are not identical. This variation is not caused by differences in apoptosis because nuclear morphology and the number of active caspase 3-positive SMCs did not differ between the various genotypes (data not shown). In summary, observations with the murine carotid artery ligation model lead us to conclude that PAI-1 and VN protect against excessive SMC proliferation. Our data provide support for a mechanism by which PAI-1, presumably in conjunction with the essential cofactor VN, controls the mitogenic activity of thrombin in the vessel wall.
Figure I. Thrombin-mediated coagulation of murine plasma
Thrombin-induced fibrin formation is measured in re-calcified EDTA plasma samples, from wild-type, VN -/-and PAI-1 -/-mice, using Thrombotest reagent (Axis-Shield, Oslo, Norway).
Thrombotest reagent contains bovine brain thromboplastin and adsorbed bovine plasma as a source for coagulation factor V and fibrinogen. Thrombotest is used to measure differences in fibrin-formation times due to reduced coagulation factors X, VII and prothrombin. The murine EDTA plasma samples were diluted 40% with 0.9% (w/v) sodium chloride and 20 µl diluted plasma sample was added to 500 µl Thrombotest reagent to measure coagulation.
As a control, the clotting time for pooled EDTA plasma derived from five control unligated mice was measured. Clotting times of re-calcified EDTA plasma samples, derived from VN -/-mice, PAI-1 -/-mice and their wild-type counterparts, were determined.
In control pooled plasma, derived from five unligated control mice, fibrin formation occurred after 36 sec. For the VN -/-and wild-type mice, the clotting times were 37 +/-2 sec (n=2) and 42 +/-4 sec (n=3), respectively. In addition, we have measured the clotting times for PAI-1 -/-and wild-type mice, being 38 +/-1 sec (n=6) and 37 +/-2 sec (n=5), respectively. Clearly, the clotting values for any of these genotypes are not significantly different. This Thrombotest assay demonstrates that thrombin, factor VII and factor X are present and can be activated in plasma of all studied genotypes after carotid artery ligation. WT indicates wild-type; -/-, deficient; ns, not significant.
